Adamas Pharmaceuticals, Inc. ADMS
8.22 +8.22
Day range unavailable
52-week range unavailable
ADMS revenue history
Revenue is income from the company’s ordinary business activities.
74,461,000 USD
FY 2020 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2020 | 2020-12-31 | 74,461,000 | 19,824,000 | 36.28% |
| FY 2019 | 2019-12-31 | 54,637,000 | 20,591,000 | 60.48% |
| FY 2018 | 2018-12-31 | 34,046,000 | 33,475,000 | 5862.52% |
| FY 2017 | 2017-12-31 | 571,000 | -1,000 | -0.17% |
| FY 2016 | 2016-12-31 | 572,000 | -1,344,000 | -70.15% |
| FY 2015 | 2015-12-31 | 1,916,000 | -53,930,000 | -96.57% |
| FY 2014 | 2014-12-31 | 55,846,000 | -15,249,000 | -21.45% |
| FY 2013 | 2013-12-31 | 71,095,000 | 33,624,000 | 89.73% |
| FY 2012 | 2012-12-31 | 37,471,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:00.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.